• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过PET/CT扫描测量健康受试者的铷-82清除率来估算肾灌注。

Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects.

作者信息

Langaa Stine Sundgaard, Lauridsen Thomas Guldager, Mose Frank Holden, Fynbo Claire Anne, Theil Jørn, Bech Jesper Nørgaard

机构信息

Gødstrup HospitalUniversity Clinic in Nephrology and Hypertension, Department of Medical Research, Gødstrup Hospital and Aarhus University, Lægaardvej 12J, 7500, Holstebro, Denmark.

Department of Nuclear Medicine, Gødstrup Hospital, Herning, Denmark.

出版信息

EJNMMI Phys. 2021 May 31;8(1):43. doi: 10.1186/s40658-021-00389-0.

DOI:10.1186/s40658-021-00389-0
PMID:34057645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8167076/
Abstract

BACKGROUND

Changes in renal blood flow (RBF) may play a pathophysiological role in hypertension and kidney disease. However, RBF determination in humans has proven difficult. We aimed to confirm the feasibility of RBF estimation based on positron emission tomography/computed tomography (PET/CT) and rubidium-82 (Rb) using the abdominal aorta as input function in a 1-tissue compartment model.

METHODS

Eighteen healthy subjects underwent two dynamic Rb PET/CT scans in two different fields of view (FOV). FOV-A included the left ventricular blood pool (LVBP), the abdominal aorta (AA) and the majority of the kidneys. FOV-B included AA and the kidneys in their entirety. In FOV-A, an input function was derived from LVBP and from AA, in FOV-B from AA. One-tissue compartmental modelling was performed using tissue time activity curves generated from volumes of interest (VOI) contouring the kidneys, where the renal clearance of Rb is represented by the K kinetic parameter. Total clearance for both kidneys was calculated by multiplying the K values with the volume of VOIs used for analysis. Intra-assay coefficients of variation and inter-observer variation were calculated.

RESULTS

For both kidneys, K values derived from AA did not differ significantly from values obtained from LVBP, neither were significant differences seen between AA in FOV-A and AA in FOV-B, nor between the right and left kidneys. For both kidneys, the intra-assay coefficients of variation were low (~ 5%) for both input functions. The measured K of 2.80 ml/min/cm translates to a total clearance for both kidneys of 766 ml/min/1.73 m.

CONCLUSION

Measurement of renal perfusion based on PET/CT and Rb using AA as input function in a 1-tissue compartment model is feasible in a single FOV. Based on previous studies showing Rb to be primarily present in plasma, the measured K clearance values are most likely representative of effective renal plasma flow (ERPF) rather than estimated RBF values, but as the accurate calculation of total clearance/flow is very much dependent on the analysed volume, a standardised definition for the employed renal volumes is needed to allow for proper comparison with standard ERPF and RBF reference methods.

摘要

背景

肾血流量(RBF)的变化可能在高血压和肾脏疾病中发挥病理生理作用。然而,已证明在人体中测定RBF具有难度。我们旨在证实基于正电子发射断层扫描/计算机断层扫描(PET/CT)和82铷(Rb),以腹主动脉作为输入函数,在单组织隔室模型中估算RBF的可行性。

方法

18名健康受试者在两个不同视野(FOV)下接受了两次动态Rb PET/CT扫描。FOV-A包括左心室血池(LVBP)、腹主动脉(AA)和大部分肾脏。FOV-B包括整个AA和双侧肾脏。在FOV-A中,输入函数分别从LVBP和AA得出,在FOV-B中从AA得出。使用勾勒肾脏轮廓的感兴趣区(VOI)生成的组织时间-活性曲线进行单组织隔室建模,其中Rb的肾脏清除率由动力学参数K表示。通过将K值与用于分析的VOI体积相乘来计算双侧肾脏的总清除率。计算批内变异系数和观察者间变异。

结果

对于双侧肾脏,从AA得出的K值与从LVBP获得的值无显著差异,FOV-A中的AA与FOV-B中的AA之间、以及右肾和左肾之间也均未观察到显著差异。对于双侧肾脏,两种输入函数的批内变异系数均较低(约5%)。测得的K值为2.80 ml/min/cm,换算为双侧肾脏的总清除率为766 ml/min/1.73 m²。

结论

在单视野下,基于PET/CT和Rb,以AA作为输入函数,在单组织隔室模型中测量肾脏灌注是可行的。基于先前显示Rb主要存在于血浆中的研究,测得的K清除率值很可能代表有效肾血浆流量(ERPF)而非估算的RBF值,但由于总清除率/流量的准确计算在很大程度上取决于所分析的体积,因此需要对所采用的肾脏体积进行标准化定义,以便与标准ERPF和RBF参考方法进行适当比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/b013f415e134/40658_2021_389_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/e571459be7d1/40658_2021_389_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/72631825a6d1/40658_2021_389_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/3f69ebed239b/40658_2021_389_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/9167dfd93f40/40658_2021_389_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/193b3b536cbb/40658_2021_389_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/73ee9058d1f6/40658_2021_389_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/01bb6e81da88/40658_2021_389_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/de9bcdbd12f5/40658_2021_389_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/b013f415e134/40658_2021_389_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/e571459be7d1/40658_2021_389_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/72631825a6d1/40658_2021_389_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/3f69ebed239b/40658_2021_389_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/9167dfd93f40/40658_2021_389_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/193b3b536cbb/40658_2021_389_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/73ee9058d1f6/40658_2021_389_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/01bb6e81da88/40658_2021_389_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/de9bcdbd12f5/40658_2021_389_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e724/8167076/b013f415e134/40658_2021_389_Fig9_HTML.jpg

相似文献

1
Estimation of renal perfusion based on measurement of rubidium-82 clearance by PET/CT scanning in healthy subjects.通过PET/CT扫描测量健康受试者的铷-82清除率来估算肾灌注。
EJNMMI Phys. 2021 May 31;8(1):43. doi: 10.1186/s40658-021-00389-0.
2
Reliability of rubidium-82 PET/CT for renal perfusion determination in healthy subjects.铷-82 PET/CT 测定健康受试者肾灌注的可靠性。
BMC Nephrol. 2022 Nov 28;23(1):379. doi: 10.1186/s12882-022-02962-w.
3
Dynamic rubidium-82 PET/CT as a novel tool for quantifying hemodynamic differences in renal blood flow using a one-tissue compartment model.动态铷-82 PET/CT 作为一种新工具,可使用单组织室模型定量评估肾血流的血液动力学差异。
Med Phys. 2024 Jun;51(6):4069-4080. doi: 10.1002/mp.17080. Epub 2024 May 6.
4
Initial human experience with Rubidium-82 renal PET/CT imaging.铷-82肾脏PET/CT成像的初步人体经验。
J Med Imaging Radiat Oncol. 2014 Feb;58(1):25-31. doi: 10.1111/1754-9485.12079. Epub 2013 May 22.
5
Mapping of local renal blood flow with PET and H(2)(15)O.利用正电子发射断层扫描(PET)和H(2)(15)O对局部肾血流进行映射。
J Nucl Med. 2002 Apr;43(4):470-5.
6
Dynamic renal blood flow measurement by positron emission tomography in patients with CRF.慢性肾功能衰竭患者中通过正电子发射断层扫描测量动态肾血流量
Am J Kidney Dis. 2002 Nov;40(5):947-54. doi: 10.1053/ajkd.2002.36325.
7
Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects.在健康受试者中使用动态FDG-PET/MRI评估肾功能参数肾小球滤过率和有效肾血浆流量。
EJNMMI Res. 2018 May 9;8(1):37. doi: 10.1186/s13550-018-0389-1.
8
Non-invasive determination of blood input function to compute rate of myocardial glucose uptake from dynamic FDG PET images of rat heart in vivo: comparative study between the inferior vena cava and the left ventricular blood pool with spill over and partial volume corrections.从大鼠活体心脏动态 FDG PET 图像中计算心肌葡萄糖摄取率的无创性血输入功能测定:下腔静脉和左心室血池与溢出和部分容积校正的比较研究。
Phys Med Biol. 2019 Aug 21;64(16):165010. doi: 10.1088/1361-6560/ab3238.
9
Metabolic liver function measured in vivo by dynamic (18)F-FDGal PET/CT without arterial blood sampling.无需采集动脉血样,通过动态(18)F-FDGal正电子发射断层显像/计算机断层扫描(PET/CT)在体内测量代谢性肝功能。
EJNMMI Res. 2015 May 14;5:32. doi: 10.1186/s13550-015-0110-6. eCollection 2015.
10
Comparison of Renal Blood Flow Using Maximum Slope-Based Computed Tomography Perfusion and Ultrasound Flow Probe in Healthy Dogs.使用基于最大斜率的计算机断层扫描灌注和超声血流探头对健康犬肾血流量的比较
Front Vet Sci. 2020 Oct 9;7:541747. doi: 10.3389/fvets.2020.541747. eCollection 2020.

引用本文的文献

1
Total-body positron emission tomography: Investigating mechanisms in cardiovascular-kidney-metabolic syndrome.全身正电子发射断层扫描:探究心血管-肾脏-代谢综合征的机制。
J Nucl Cardiol. 2025 Jul 5:102299. doi: 10.1016/j.nuclcard.2025.102299.
2
Relationship between renal oxidative stress levels and disease severity in patients with chronic kidney disease assessed by [Cu-64]ATSM PET/MRI.通过[铜-64]ATSM正电子发射断层扫描/磁共振成像评估慢性肾脏病患者肾脏氧化应激水平与疾病严重程度之间的关系。
Sci Rep. 2025 Feb 28;15(1):7227. doi: 10.1038/s41598-024-85027-2.
3
Renal clearance estimated by rubidium-82 positron emission tomography/computed tomography and technetium-99m-mercaptoacetyltriglycine clearance infusion technique.

本文引用的文献

1
Renal cortical volume: High correlation with pre- and post-operative renal function in living kidney donors.肾皮质体积:与活体供肾者术前术后肾功能的高度相关性。
Eur J Radiol. 2018 Feb;99:118-123. doi: 10.1016/j.ejrad.2017.12.013. Epub 2017 Dec 21.
2
Evaluation of Renal Blood Flow in Chronic Kidney Disease Using Arterial Spin Labeling Perfusion Magnetic Resonance Imaging.使用动脉自旋标记灌注磁共振成像评估慢性肾脏病患者的肾血流
Kidney Int Rep. 2017 Jan;2(1):36-43. doi: 10.1016/j.ekir.2016.09.003. Epub 2016 Sep 13.
3
Quantification of myocardial blood flow with (82)Rb: Validation with (15)O-water using time-of-flight and point-spread-function modeling.
通过铷-82正电子发射断层扫描/计算机断层扫描和锝-99m-巯基乙酰三甘氨酸清除率输注技术估算的肾清除率。
Clin Physiol Funct Imaging. 2025 Mar;45(2):e70000. doi: 10.1111/cpf.70000.
4
Randomized, Placebo-Controlled Trial on the Renal and Systemic Hemodynamic Effects of Empagliflozin.恩格列净对肾脏和全身血流动力学影响的随机、安慰剂对照试验
Kidney Int Rep. 2024 Oct 29;10(1):134-144. doi: 10.1016/j.ekir.2024.10.019. eCollection 2025 Jan.
5
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).恩格列净在伴有或不伴有慢性肾脏病的 2 型糖尿病和非糖尿病性慢性肾脏病中的作用:3 项交叉随机对照试验的方案(SiRENA 项目)。
JMIR Res Protoc. 2024 May 29;13:e56067. doi: 10.2196/56067.
6
Feasibility of Simultaneous Quantification of Myocardial and Renal Perfusion With Cardiac Positron Emission Tomography.心肌和肾脏灌注的心脏正电子发射断层成像同步定量的可行性。
Circ Cardiovasc Imaging. 2023 Sep;16(9):e015324. doi: 10.1161/CIRCIMAGING.123.015324. Epub 2023 Sep 1.
7
Reliability of rubidium-82 PET/CT for renal perfusion determination in healthy subjects.铷-82 PET/CT 测定健康受试者肾灌注的可靠性。
BMC Nephrol. 2022 Nov 28;23(1):379. doi: 10.1186/s12882-022-02962-w.
用⁸²Rb定量心肌血流量:使用飞行时间和点扩散函数建模,以⁵O-水进行验证。
EJNMMI Res. 2016 Dec;6(1):68. doi: 10.1186/s13550-016-0215-6. Epub 2016 Aug 1.
4
A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.可靠性研究中组内相关系数选择与报告指南
J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31.
5
Evaluation of Renal Blood Flow and Oxygenation in CKD Using Magnetic Resonance Imaging.利用磁共振成像评估慢性肾脏病患者的肾血流和氧合状态。
Am J Kidney Dis. 2015 Sep;66(3):402-11. doi: 10.1053/j.ajkd.2014.11.022. Epub 2015 Jan 22.
6
Initial human experience with Rubidium-82 renal PET/CT imaging.铷-82肾脏PET/CT成像的初步人体经验。
J Med Imaging Radiat Oncol. 2014 Feb;58(1):25-31. doi: 10.1111/1754-9485.12079. Epub 2013 May 22.
7
PET tracers and techniques for measuring myocardial blood flow in patients with coronary artery disease.用于测量冠心病患者心肌血流的正电子发射断层显像(PET)示踪剂和技术。
J Biomed Res. 2013 Nov;27(6):452-9. doi: 10.7555/JBR.27.20130136. Epub 2013 Sep 25.
8
Tolerance of the human kidney to isolated controlled ischemia.人类肾脏对孤立性控制性缺血的耐受能力。
J Am Soc Nephrol. 2013 Feb;24(3):506-17. doi: 10.1681/ASN.2012080786. Epub 2013 Feb 14.
9
Quantification of regional myocardial blood flow estimation with three-dimensional dynamic rubidium-82 PET and modified spillover correction model.采用三维动态铷-82 PET 和改良的溢出校正模型对局部心肌血流进行定量评估。
J Nucl Cardiol. 2012 Aug;19(4):763-74. doi: 10.1007/s12350-012-9558-1. Epub 2012 Apr 14.
10
Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation.相位对比磁共振成像测量脓毒症急性肾损伤时的肾血流量:一项初步研究。
Crit Care Med. 2012 Jun;40(6):1768-76. doi: 10.1097/CCM.0b013e318246bd85.